UK Biotechs Maintain Fundraising During Pandemic
Sector's First NASDAQ IPO Of 2020 Expected Soon
Executive Summary
Buoyed by belief in its strengths, the UK biotech sector has defied the pandemic over the last three months – but smaller firms are still strapped for cash.